SAMSUNG EPISHOLDINGS CO LTD
Samsung Epis Holdings Co., Ltd., a biotechnology company, manage the portfolio of biopharmaceutical products. The company was founded in 2025 and is based in Incheon, South Korea.
Market Cap & Net Worth: SAMSUNG EPISHOLDINGS CO LTD (0126Z0)
SAMSUNG EPISHOLDINGS CO LTD (KO:0126Z0) has a market capitalization of $8.75 Billion (₩12.81 Trillion) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #32514 globally and #2095 in its home market, demonstrating a -5.33% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SAMSUNG EPISHOLDINGS CO LTD's stock price ₩515000.00 by its total outstanding shares 24883049 (24.88 Million).
SAMSUNG EPISHOLDINGS CO LTD Market Cap History: 2025 to 2026
SAMSUNG EPISHOLDINGS CO LTD's market capitalization history from 2025 to 2026. Data shows growth from $12.63 Billion to $8.75 Billion (0.00% CAGR).
SAMSUNG EPISHOLDINGS CO LTD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SAMSUNG EPISHOLDINGS CO LTD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0126Z0 by Market Capitalization
Companies near SAMSUNG EPISHOLDINGS CO LTD in the global market cap rankings as of March 18, 2026.
Key companies related to SAMSUNG EPISHOLDINGS CO LTD by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
SAMSUNG EPISHOLDINGS CO LTD Historical Marketcap From 2025 to 2026
Between 2025 and today, SAMSUNG EPISHOLDINGS CO LTD's market cap moved from $12.63 Billion to $ 8.75 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩8.75 Billion | -30.69% |
| 2025 | ₩12.63 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of SAMSUNG EPISHOLDINGS CO LTD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.75 Billion USD |
| MoneyControl | $8.75 Billion USD |
| MarketWatch | $8.75 Billion USD |
| marketcap.company | $8.75 Billion USD |
| Reuters | $8.75 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.